Posted by Michael Wonder on 07 Feb 2022
Health economic assessment of Opdivo in cancer of the oesophagus or upper gastro-intestinal tract
7 February 2022 - TLV has produced a health economic assessment for the regions for Opdivo (nivolumab).
The assessment concerns the treatment of adult patients with oesophageal cancer or cancer of the upper stomach who have undergone surgery.
